Han Lin
Jiangnan University
11 Papers
Han Lin is an academic researcher from Jiangnan University. The author has contributed to research in topics: Chemistry & Cancer immunotherapy. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant
TL;DR: This review highlights recent advances in developing full synthetic carbohydrate antigen based vaccines, with an emphasis on the structure-activity relationships that provide a primary basis for future vaccine design and immunotherapy developing.
37
Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204
Dan Li,Liang Gong,Han Lin,Surui Yao,Yuanwan Yin,Zhifang Zhou,Jie Shi,Zhimeng Wu,Zhaohui Huang +8 more
TL;DR: HA-decorated bovine milk exosomes can be proven to be a practical drug delivery system of RNA drugs for targeted cancer therapy and showed excellent biocompatibility and did not cause significant systemic toxicity.
Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen
TL;DR: The immune responses against sTn have been significantly augmented with the involvement of Rha-specific antibodies to enhance antigen uptake.
19
Synthesis of DNP-modified GM3-based anticancer vaccine and evaluation of its immunological activities for cancer immunotherapy
TL;DR: Mice immunological studies revealed that the DNP-modified GM3 (GM3-NHDNP) analog elicited strong and rapid immune responses by recruiting anti-DNP antibodies to facilitate the targeted delivery of the vaccine construct to antigen processing cells (APCs).
11
Dinitrophenol-Hyaluronan Conjugates as Multivalent Antibody-Recruiting Glycopolymers for Targeted Cancer Immunotherapy
Han Lin,Kun Zhou,Dan Li,Haofei Hong,Yuntian Xie,Liang Gong,Yu Shen,Zhifang Zhou,Jie Shi,Zhimeng Wu +9 more
TL;DR: In this article, a multivalent antibody-recruiting glycopolymers (MARGs) composed of hyaluronic acid (HA) grafted with multiple copies of dinitrophenol (DNP) were developed for targeted cancer immunotherapy.
8